• CLAZAKIZUMAB chembl:CHEMBL2108589 Antineoplastic

    Alternate Names:

    ALD518
    CLAZAKIZUMAB
    BMS-945429
    ALD-518

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antineoplastic agent
    (1 More Sources)

    Publications:

  • Interaction Score: 7.66

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction Interleukin-6 inhibitor
    Direct Interaction yes
    Trial Name ALD518, BMS-945429

    PMIDs:
    None found


    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class monoclonal antibody
    FDA Approval not approved

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D04RMM TTD Drug ID

    Drug Info:

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D0N0BW TTD Drug ID

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: